Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Reference Guide
  /  
APOA4
Sign up free to test for 
APOA4
.
One login for 30+ lab companies.

APOA4

The need for an advanced understanding of lipidology structure and function in healthcare is growing.   Lipoprotein testing provides valuable insights into an individual's lipid profile, aiding in the assessment of cardiovascular risk and guiding interventions above and beyond the standard lipid panel.  

Apolipoprotein ApoA4 plays a role in lipid metabolism and cardiovascular health, beginning with the packaging of chylomicrons during fat absorption.

Beyond its intestinal functions, apoA4 is found on chylomicron remnants, high-density lipoproteins, and in lipid-free form within the circulation. 

Its physiological roles include lipid metabolism, anti-atherosclerosis mechanisms, regulation of platelet aggregation and thrombosis, maintenance of glucose homeostasis, and modulation of food intake. 

Notably, deficiency in apoA4 has been linked to conditions like atherosclerosis and diabetes, underscoring its potential as a therapeutic target.

Understanding ApoA4

What is ApoA4?

Apolipoprotein A4 (ApoA4) is a protein involved in lipid metabolism.  It is primarily synthesized in the small intestine and incorporated into chylomicrons during fat absorption, which are then secreted into the intestinal lymph. 

ApoA4 is found not only on chylomicron remnants but also on high-density lipoproteins and in lipid-free form within the circulation. Its functions extend beyond lipid metabolism, encompassing roles in anti-atherosclerosis mechanisms, platelet aggregation regulation, glucose homeostasis, and even modulation of food intake.  [14.]

Deficiency in apoA4 has been associated with conditions like atherosclerosis and diabetes, highlighting its significance as a potential therapeutic target for treating these diseases.

How are ApoA4 Lipoproteins and HDL Particles Related?

Apolipoprotein A4 (apoA4) is closely associated with high-density lipoprotein (HDL) particles, playing a crucial role in their structure and function. 

As a lipid-binding protein synthesized primarily in the small intestine in the presence of dietary fat, apoA4 is secreted into the intestinal lymph and subsequently becomes a component of chylomicron remnants. 

As chylomicrons are broken down ApoA4 is released In the circulation, and some of this ApoA4 subsequently attaches to circulating HDL particles.  [15.]

Its presence on HDL contributes to the stability and functionality of these lipoproteins, aiding in their role of reverse cholesterol transport.  [13.]

Additionally, apoA4’s interaction with HDL particles is implicated in various physiological processes including anti-atherosclerotic effects, antioxidant and anti-inflammatory properties, and regulation of lipid metabolism.  [13.]

ApoA4 and Glucose Metabolism

In addition to its role in lipid metabolism, apolipoprotein A4 also has significant functions in glucose metabolism.  [15.]

It has been found to inhibit gluconeogenesis in hepatocytes, promote glucose uptake in adipocytes, and enhance insulin secretion in pancreatic islets. [15]  It may be an important link between hepatic glucose and lipid metabolism.  [16.]

ApoA4 has also been shown to regulate food intake through the central nervous system.  [5.] 

APOA4 is also suggested as a potential early diagnostic biomarker for prediabetes, liver fibrosis, and impaired renal function. [3.]  Additionally, genetic studies have identified associations between APOA4 genetic variations and dyslipidemia, as well as responses to lipid-lowering treatments such as fenofibrate.

Function of ApoA4 in Cardiovascular Health

Apolipoprotein A-IV (APOA4) plays a crucial role in modulating cardiovascular disease risk through its multifaceted involvement in lipid metabolism, glucose homeostasis, inflammation, and atherosclerosis.

Clinical studies indicate an inverse relationship between plasma APOA4 levels and coronary artery disease.  [6.]

Moreover, APOA4 exhibits protective effects against inflammation and atherosclerosis, and prevents platelet aggregation and thrombosis.  [13.]

Clinical Significance of ApoA4 Levels

The clinical significance of ApoA4 levels is still being understood.  ApoA4 is associated with protective effects against various metabolic disorders and cardiovascular diseases. Elevated apoA4 levels have been linked to improved insulin sensitivity, reduced risk of coronary artery disease, and improved outcomes in obesity-related comorbidities, suggesting a protective role against metabolic syndrome. 

However, elevated APoA4 levels have also been correlated with the progression of renal impairment in type 2 diabetics.  [3.]

Further research is needed to fully understand the implications of ApoA4 in clinical practice.  

ApoA4 Testing Options

Overview of ApoA4 Testing

ApoA4 testing involves assessing the levels of apolipoprotein A4 (ApoA4) in the bloodstream, typically through blood serum or plasma samples.  Venipuncture is commonly required.  This test is infrequently ordered.  

Genetic testing to identify genetic polymorphisms of ApoA4 are also available.  

More commonly,  apolipoprotein testing including testing for ApoA1, ApoB, and ApoE, is available to provide additional insight into an individual’s cardiovascular risk profile.  

Natural Ways to Optimize ApoA4 Levels

Dietary Strategies

Diets Containing Fermented Dairy Products: diets containing fermented dairy products have been shown to improve lipoprotein levels.  [4., 10.]  

Foods Rich in Omega-3 Fatty Acids: Fatty fish (salmon, mackerel, sardines), flaxseeds, chia seeds, walnuts all have scientific evidence of efficacy in improving lipoprotein profiles and reducing cardiovascular disease risk.  [4., 10.]

Fiber-Rich Foods: Whole grains (oats, barley, quinoa), fruits (apples, berries, oranges), vegetables (broccoli, Brussels sprouts, carrots), legumes (beans, lentils) are all Mediterranean diet staples that have shown effectiveness in reducing cardiovascular disease risk.  [10.]

Avoid excess sugar: diets high in sugar are highly correlated with poor cardiometabolic health outcomes.  [4.]

Lifestyle Modifications

Regular Exercise: Aerobic activities (walking, jogging, swimming), strength training, yoga, tai chi may all benefit lipoprotein levels and promote cardiovascular health.  [4., 18.]

Smoking Cessation: Quitting smoking reduces oxidative stress and inflammation, contributing to improved lipid profiles.  [4.]

Stress Management: Techniques such as meditation, deep breathing exercises, yoga, and mindfulness may help lower stress levels and improve overall cardiovascular health,and in some cases may also have a positive effect on lipid profiles.  [12.]

Niacin (Vitamin B3): Niacin supplementation has been shown to increase ApoA1 levels and improve HDL cholesterol levels.  [2.]

Testing Options for Lipoprotein Levels in Cardiovascular Health

Click here to learn more about testing options for lipoprotein levels and order tests.

What's 
APOA4
?
If Your Levels Are High
Symptoms of High Levels
If Your Levels are Low
Symptoms of Low Levels
See References

[1.] Bailey A, Mohiuddin SS. Biochemistry, High Density Lipoprotein. [Updated 2022 Sep 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549802/ 

[2.] Brown WM, Chiacchia FS. Therapies to Increase ApoA-I and HDL-Cholesterol Levels. Drug Target Insights. 2008;3. doi:10.4137/DTI.S447

[3.] Cheng CW, Chang CC, Chen HW, Lin CY, Chen JS. Serum ApoA4 levels predicted the progression of renal impairment in T2DM. Eur J Clin Invest. 2018 Jun;48(6):e12937. doi: 10.1111/eci.12937. Epub 2018 May 13. PMID: 29675916.

‌[4.] Frondelius K, Borg M, Ericson U, Borné Y, Melander O, Sonestedt E. Lifestyle and Dietary Determinants of Serum Apolipoprotein A1 and Apolipoprotein B Concentrations: Cross-Sectional Analyses within a Swedish Cohort of 24,984 Individuals. Nutrients. 2017 Feb 28;9(3):211. doi: 10.3390/nu9030211. PMID: 28264492; PMCID: PMC5372874. 

[5.] Fujimoto K, Fukagawa K, Sakata T, Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest. 1993 Apr;91(4):1830-3. doi: 10.1172/JCI116395. PMID: 8473522; PMCID: PMC288165.

[6.] Kronenberg F, Stühlinger M, Trenkwalder E, Geethanjali FS, Pachinger O, von Eckardstein A, Dieplinger H. Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. J Am Coll Cardiol. 2000 Sep;36(3):751-7. doi: 10.1016/s0735-1097(00)00775-0. PMID: 10987595.

[7.] Kuyl JM, Mendelsohn D. Observed relationship between ratios HDL-cholesterol/total cholesterol and apolipoprotein A1/apolipoprotein B. Clin Biochem. 1992 Oct;25(5):313-6. doi: 10.1016/0009-9120(92)80004-z. PMID: 1490290.

[8.] Morris G, Puri BK, Bortolasci CC, et al. The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders. Neuroscience & Biobehavioral Reviews. 2021;125:244-263. doi:https://doi.org/10.1016/j.neubiorev.2021.02.037 

[9.] Mustad V, Derr J, Reddy CC, Pearson TA, Kris-Etherton PM. Seasonal variation in parameters related to coronary heart disease risk in young men. Atherosclerosis. 1996 Sep 27. 126(1):117-29.

[10.] Nacarelli GS, Fasolino T, Davis S. Dietary, macronutrient, micronutrient, and nutrigenetic factors impacting cardiovascular risk markers apolipoprotein B and apolipoprotein A1: a narrative review. Nutrition Reviews. Published online August 23, 2023:nuad102. doi:https://doi.org/10.1093/nutrit/nuad102 

[11.] Nazir S, Jankowski V, Bender G, Zewinger S, Rye KA, van der Vorst EPC. Interaction between high-density lipoproteins and inflammation: Function matters more than concentration! Advanced Drug Delivery Reviews. 2020;159:94-119. doi:https://doi.org/10.1016/j.addr.2020.10.006

[12.] Papp ME, Lindfors P, Nygren-Bonnier M, Gullstrand L, Wändell PE. Effects of High-Intensity Hatha Yoga on Cardiovascular Fitness, Adipocytokines, and Apolipoproteins in Healthy Students: A Randomized Controlled Study. J Altern Complement Med. 2016 Jan;22(1):81-7. doi: 10.1089/acm.2015.0082. Epub 2015 Nov 13. Erratum in: J Altern Complement Med. 2017 May;23(5):396. PMID: 26565690; PMCID: PMC4739349.

[13.] Peng J, Li XP. Apolipoprotein A-IV: A potential therapeutic target for atherosclerosis. Prostaglandins Other Lipid Mediat. 2018 Nov;139:87-92. doi: 10.1016/j.prostaglandins.2018.10.004. Epub 2018 Oct 22. PMID: 30352313.

[14.] Qu J, Ko CW, Tso P, Bhargava A. Apolipoprotein A-IV: A Multifunctional Protein Involved in Protection against Atherosclerosis and Diabetes. Cells. 2019 Apr 5;8(4):319. doi: 10.3390/cells8040319. PMID: 30959835; PMCID: PMC6523623.

[15.] Qu J, Fourman S, Fitzgerald M, et al. Low-density lipoprotein receptor-related protein 1 (LRP1) is a novel receptor for apolipoprotein A4 (APOA4) in adipose tissue. Scientific Reports. 2021;11(1):13289. doi:https://doi.org/10.1038/s41598-021-92711-0 

[16.] Wang Z, Wang L, Zhang Z, Feng L, Song X, Wu J. Apolipoprotein A-IV involves in glucose and lipid metabolism of rat. Nutrition & Metabolism. 2019;16(1). doi:https://doi.org/10.1186/s12986-019-0367-2

[17.] Xu XR, Wang Y, Adili R, Ju L, Spring CM, Jin JW, Yang H, Neves MAD, Chen P, Yang Y, Lei X, Chen Y, Gallant RC, Xu M, Zhang H, Song J, Ke P, Zhang D, Carrim N, Yu SY, Zhu G, She YM, Cyr T, Fu W, Liu G, Connelly PW, Rand ML, Adeli K, Freedman J, Lee JE, Tso P, Marchese P, Davidson WS, Jackson SP, Zhu C, Ruggeri ZM, Ni H. Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis. Nat Commun. 2018 Sep 6;9(1):3608. doi: 10.1038/s41467-018-05806-0. PMID: 30190457; PMCID: PMC6127106.

[18.] Yazdani R, Marefati H, Shahesmaeili A, Nakhaei S, Bagheri A, Dastoorpoor M. Effect of Aerobic Exercises on Serum Levels of Apolipoprotein A1 and Apolipoprotein B, and Their Ratio in Patients with Chronic Obstructive Pulmonary Disease. Tanaffos. 2018 Feb;17(2):82-89. PMID: 30627178; PMCID: PMC6320561.

Test for

APOA4

No items found.
Order, track, and receive results from 30+ labs in one place.